Pathogen exposure misclassification can bias association signals in GWAS of infectious diseases when using population-based common control subjects.

GWAS common controls genetic epidemiology infectious disease misclassification bias population-based controls

Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
02 02 2023
Historique:
received: 13 06 2022
accepted: 20 12 2022
pubmed: 18 1 2023
medline: 8 2 2023
entrez: 17 1 2023
Statut: ppublish

Résumé

Genome-wide association studies (GWASs) have been performed to identify host genetic factors for a range of phenotypes, including for infectious diseases. The use of population-based common control subjects from biobanks and extensive consortia is a valuable resource to increase sample sizes in the identification of associated loci with minimal additional expense. Non-differential misclassification of the outcome has been reported when the control subjects are not well characterized, which often attenuates the true effect size. However, for infectious diseases the comparison of affected subjects to population-based common control subjects regardless of pathogen exposure can also result in selection bias. Through simulated comparisons of pathogen-exposed cases and population-based common control subjects, we demonstrate that not accounting for pathogen exposure can result in biased effect estimates and spurious genome-wide significant signals. Further, the observed association can be distorted depending upon strength of the association between a locus and pathogen exposure and the prevalence of pathogen exposure. We also used a real data example from the hepatitis C virus (HCV) genetic consortium comparing HCV spontaneous clearance to persistent infection with both well-characterized control subjects and population-based common control subjects from the UK Biobank. We find biased effect estimates for known HCV clearance-associated loci and potentially spurious HCV clearance associations. These findings suggest that the choice of control subjects is especially important for infectious diseases or outcomes that are conditional upon environmental exposures.

Identifiants

pubmed: 36649706
pii: S0002-9297(22)00547-X
doi: 10.1016/j.ajhg.2022.12.013
pmc: PMC9943744
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

336-348

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI148049
Pays : United States
Organisme : NHGRI NIH HHS
ID : R35 HG011944
Pays : United States

Informations de copyright

Copyright © 2022 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests All authors declare no competing interests.

Références

Am J Hum Genet. 2017 Jul 6;101(1):5-22
pubmed: 28686856
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Nat Genet. 2018 Sep;50(9):1335-1341
pubmed: 30104761
Ann Intern Med. 2013 Feb 19;158(4):235-45
pubmed: 23420232
Am J Epidemiol. 2007 Jun 15;165(12):1443-53
pubmed: 17379617
Bioinformatics. 2010 Nov 15;26(22):2867-73
pubmed: 20926424
Glycobiology. 2008 Dec;18(12):1085-93
pubmed: 18818423
Nat Rev Genet. 2022 Nov;23(11):665-679
pubmed: 35581355
Nat Genet. 2022 Apr;54(4):368-369
pubmed: 35410380
Nat Genet. 2018 Nov;50(11):1593-1599
pubmed: 30349118
Pathogens. 2012 Nov 08;1(2):156-74
pubmed: 25436768
Nat Genet. 2019 Mar;51(3):481-493
pubmed: 30804560
Clin Infect Dis. 2021 Jul 15;73(2):328-331
pubmed: 32750119
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Epidemiol Infect. 2011 Jan;139(1):27-40
pubmed: 20920380
Bioinformatics. 2012 Dec 15;28(24):3326-8
pubmed: 23060615
Sci Adv. 2019 Oct 23;5(10):eaaw9206
pubmed: 31681842
Evid Based Ment Health. 2019 Nov;22(4):153-160
pubmed: 31563865
Gastroenterology. 2019 Apr;156(5):1496-1507.e7
pubmed: 30593799
Hum Mol Genet. 2018 Oct 15;27(20):3641-3649
pubmed: 30124842
Nature. 2009 Sep 17;461(7262):399-401
pubmed: 19684573
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Genes Immun. 2014 Apr;15(4):241-6
pubmed: 24622687
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
BMJ Open. 2018 Aug 22;8(8):e022344
pubmed: 30135186
Clin Microbiol Rev. 2015 Jul;28(3):801-70
pubmed: 26085552
Nat Genet. 2021 May;53(5):663-671
pubmed: 33888908
Am J Hum Genet. 2019 Jan 3;104(1):65-75
pubmed: 30595370
Nat Genet. 2016 Jul;48(7):817-20
pubmed: 27270105
Nat Med. 2020 Feb;26(2):252-258
pubmed: 32042192
Nat Commun. 2020 Nov 12;11(1):5749
pubmed: 33184277
Cell. 2016 Nov 17;167(5):1415-1429.e19
pubmed: 27863252
Rev Med Virol. 2010 Jul;20(4):202-13
pubmed: 20564615
Nature. 2021 Mar;591(7848):92-98
pubmed: 33307546
Obesity (Silver Spring). 2013 Apr;21(4):835-46
pubmed: 23712987
Infect Genet Evol. 2018 Dec;66:286-307
pubmed: 28951201
Am J Hum Genet. 2016 Nov 3;99(5):1130-1139
pubmed: 27773431
Nat Commun. 2021 Feb 9;12(1):886
pubmed: 33563987
Addiction. 2022 Jul;117(7):1908-1919
pubmed: 35129232
Nat Rev Dis Primers. 2021 Jun 24;7(1):45
pubmed: 34168126
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Syst Rev. 2018 Jun 2;7(1):82
pubmed: 29859533
Nat Genet. 2021 Jul;53(7):1097-1103
pubmed: 34017140
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Int J Epidemiol. 2012 Feb;41(1):273-86
pubmed: 22253303
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
Nat Genet. 2018 Aug;50(8):1112-1121
pubmed: 30038396
Nature. 2009 Oct 8;461(7265):798-801
pubmed: 19759533
Front Genet. 2014 Apr 29;5:95
pubmed: 24808905
Nat Commun. 2019 Apr 23;10(1):1891
pubmed: 31015401
Nature. 2007 Jun 7;447(7145):661-78
pubmed: 17554300
Int J Equity Health. 2020 Jul 29;19(1):126
pubmed: 32727486
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Am J Hum Genet. 2008 Jul;83(1):132-5; author reply 135-9
pubmed: 18606306
Genetics. 2014 Jun;197(2):573-89
pubmed: 24700103
J Allergy Clin Immunol. 2020 Feb;145(2):537-549
pubmed: 31669095
Nat Genet. 2016 Nov;48(11):1443-1448
pubmed: 27694958
Gastroenterology. 2010 Apr;138(4):1338-45, 1345.e1-7
pubmed: 20060832
Int J Epidemiol. 2018 Feb 1;47(1):226-235
pubmed: 29040562
Nucleic Acids Res. 2022 Jan 7;50(D1):D988-D995
pubmed: 34791404
Am J Hum Genet. 2016 Mar 3;98(3):456-472
pubmed: 26924531
Nat Genet. 2021 Jun;53(6):801-808
pubmed: 33888907
Nature. 2020 Aug;584(7822):619-623
pubmed: 32581359
Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1277-1285
pubmed: 30355406
BMC Med. 2014 Apr 10;12:61
pubmed: 24722122
Infection. 2021 Feb;49(1):15-28
pubmed: 32860214
Hum Mol Genet. 2019 Jan 1;28(1):166-174
pubmed: 30239722

Auteurs

Dylan Duchen (D)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Candelaria Vergara (C)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Chloe L Thio (CL)

Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.

Prosenjit Kundu (P)

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Nilanjan Chatterjee (N)

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

David L Thomas (DL)

Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.

Genevieve L Wojcik (GL)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Priya Duggal (P)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: pduggal@jhu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH